|
|
|
Features
The development of the Romanian drug market was severely affected in 2009 by government measures introduced to control Rx drug price increases. The introduction of a fixed exchange rate for the calculation of the prices ... more »
2010-02-24
The year 2008 saw the introduction of regulatory fees in the Czech Republic for surgery and emergency room visits, hospital stays and prescriptions. It was also a year during which the Czech Republic continued its healthcare ... more »
2010-02-10
After several months of announcements, the Polish Health Ministry has published the update to the new reimbursement lists. The new law came into effect on 16 December 2009. It vividly shows the cost-containment policy ... more »
2010-01-27
Access to innovative multiple sclerosis (MS) treatments in Central and Eastern European (CEE) countries is significantly more limited than it is in the “old” European Union countries. Access to innovative ... more »
2010-01-13
The Central and Eastern European (CEE) area is considered to be a very attractive location for clinical trials. This is because of the lower costs, the large population and the lack of patient access to innovative ... more »
2009-12-21
While some Western European countries witnessed some easing of their economic woes, conditions remained very challenging in Central and Eastern Europe in the third quarter of 2009, and pressure remained on the healthcare ... more »
2009-12-09
The pharmaceutical market in Central and Eastern Europe (CEE) is dominated by generic drugs. This subdivision was worth €17.2bn in 2008 and is expected to develop by around 14% per annum between 2009 and 2011. ... more »
2009-11-25
Among the six CEE countries analysed, the Czech Republic took the lead in terms of its healthcare system, which was evaluated as stable and maintaining good standards despite the crisis. At the other end of the scale, ... more »
2009-11-12
see more
features »
|
|
Central Europe Pharma NewsNewsletter delivering news and analysis of the pharmaceutical sector in Bulgaria, Czech Republic, Hungary, Romania, Poland and Slovakia, including an in-depth feature on the pharmaceutical industry in the Central and Eastern Europe.
more »
Central Europe Pharma OnlineOnline resource for the pharmaceutical industry in the Central & Eastern Europe region providing news, articles and market data on manufacturers and distributors, medical news and research developments.
more »
Pharma Poland OnlineNews service providing news, articles and market data on the pharmaceutical market in Poland, from manufacturers and distributors to medical devices and research developments. There is a broad archive since 2004 available.
more »
Pharma Poland NewsNewsletter covering the pharmaceutical sector in Poland - weekly and monthly newsletters containing news and analyses, both delivered by email in pdf format
more »
|
Copyright © 2010 PMR. All rights reserved.
PMR is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern Europe as well as other emerging markets. PMR key areas of operation include
business publications (through PMR Publications),
consultancy (through PMR Consulting) and
market research (through PMR Research). With over thirteen years of experience, high international standards in projects and publications, highly skilled multilingual staff and a wide network of co-operating research companies and market experts, PMR is one of the largest companies of its type in the region.